-
5 Articles
-
2 Photos
-
0 Vidéos
-
DengYueMed/Hong Kong Dengyue Pharmaceutical Limited à HONG KONG DENGYUE PHARMACEUTICAL CO., LIMITED
-
Habitant New Territories
-
Du Tai Tak Industrial Building
-
Étudié HONG KONG DENGYUE PHARMACEUTICAL CO., LIMITED à Hong Kong Dengyue Pharmaceutical LimitedClasse de https://dengyuemed.com/
-
08/09/2005
-
Suivi par 0 membre
Mises à jour récentes
-
China's Innovative Drug Exports Skyrocket in 2025: A Watershed Moment for Global PharmaBy DengYueMed As we wrap up 2025, the pharmaceutical landscape in China has undergone a seismic shift, one that positions the country not just as a manufacturing powerhouse but as a global innovator in drug development. From my vantage point at DengYueMed, where we've been tracking Asia-Pacific biotech trends for over a decade, the explosion in China's innovative drug exports—or...0 Commentaires 0 Parts 675 Vue 0 AperçuConnectez-vous pour aimer, partager et commenter!
-
China's Innovative Drug Export: Accelerating a New Era of GlobalizationIn the rapidly evolving pharmaceutical landscape of 2025, Chinese innovative drug companies are not just participating but leading on the international stage with remarkable speed and ambition. This surge is driven by a combination of technological advancements, supportive government policies, and strategic global partnerships. Over the past 24 hours alone, several pivotal developments have...0 Commentaires 0 Parts 735 Vue 0 Aperçu
-
0 Commentaires 0 Parts 559 Vue 0 Aperçu
-
My Experience with Mazdutide Injection for Weight Control: Shedding Pounds and Gaining Confidence with DengYueMedHey everyone, I'm Sarah, a 35-year-old mom of two who's been on a rollercoaster with my weight for years. Like many of you, I've tried everything from fad diets to intense workout regimes, but nothing stuck long-term. That all changed when I discovered Mazdutide injection for weight control. I want to share my personal experience in hopes it might help someone else out there who's struggling....0 Commentaires 0 Parts 854 Vue 0 Aperçu
-
0 Commentaires 0 Parts 672 Vue 0 Aperçu
Plus de lecture